Comparison of Efficacy and Safety of Caspofungin Versus Micafungin in Pediatric Allogeneic Stem Cell Transplant Recipients: A Retrospective Analysis.

Natalia MaximovaGiulia SchillaniRoberto SimeoneAlessandra MaestroDavide Zanon

Published in: Advances in therapy (2017)

These results demonstrate good efficacy and tolerability for caspofungin and micafungin. However, better results with respect to the incidence and resolution of fever in the micafungin group may suggest its use in preference to that of caspofungin.

Keyphrases

stem cells
stem cell transplantation
bone marrow
risk factors
randomized controlled trial
young adults
double blind
mesenchymal stem cells
low dose
placebo controlled
childhood cancer